BioSpace News Archive

Bio-Techne Corporation announced that Humana has awarded a contract effective April 1, 2021 to its Exosome Diagnostics laboratory, covering the ExoDx™ Prostate test for men.

Oxular Limited, a leading retinal therapeutics development company, announced that it has completed a $37 million financing led by Forbion.

Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced today that it will release its fourth quarter and year-end 2020 financial results on Monday, March 8 , after the close of the U.S. financial market

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today announced that IMV’s executive management team will be participating at the H.C. Wainwright Global Life Sciences Conference which will be held virtually on March 9-10.

EchoInsight® Strain imaging Standardizes Analysis and Interpretation, while Improving Diagnostic Assessment and Optimizing Care Through Better Patient Monitoring